Effects of the GLP-1 analogue liraglutide on ectopic fat distribution and sex hormones in women with PCOS: a randomised, clinical trial

被引：0
|
作者：
Frossing, S. [1 ,2 ]
Nylander, M. [2 ,3 ]
Kistorp, C. [1 ,2 ]
Skouby, S. O. [2 ,3 ]
Faber, J. [1 ,2 ]
机构：
[1] Herlev Univ Hosp, Endocrine Unit, Internal Med, Copenhagen, Denmark
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Herlev Univ Hosp, Gynecol & Obstet, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
806
引用
收藏
页码：S385 / S385
页数：1
相关论文
共 50 条
  • [21] Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study
    Jensterle, Mojca
    Pirs, Bostjan
    Goricar, Katja
    Dolzan, Vita
    Janez, Andrej
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (07) : 817 - 824
  • [22] Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial
    Neeland, Ian J.
    Marso, Steven P.
    Ayers, Colby R.
    Lewis, Bienka
    Oslica, Robert
    Francis, Wynona
    Rodder, Susan
    Pandey, Ambarish
    Joshi, Parag H.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (09): : 595 - 605
  • [23] Distinct effects of imeglimin on insulin, GLP-1 and GIP secretion compared to metformin: a randomised controlled trial
    Imura, M.
    Usui, R.
    Hamamoto, Y.
    Omori, Y.
    Kurotobi, Y.
    Kuwata, H.
    Tatsuoka, H.
    Shimomura, K.
    Murotani, K.
    Yamada, Y.
    Seino, Y.
    DIABETOLOGIA, 2024, 67 : S324 - S324
  • [24] GLP-1 Receptor Agonist Liraglutide Increased IVF Pregnancy Rates in Obese Women with PCOS and Previous Poor Response to First-Line Reproductive Treatments
    Janez, Andrej
    Jensterle, Mojca
    DIABETES, 2018, 67
  • [25] Sustained Weight Loss and Acceptable Tolerability With the GLP-1 Analogue Liraglutide in Obese Non-Diabetic Adults: A 2-Year Randomized Trial
    Lean, Michael E. J.
    Astrup, Arne
    Al Hakim, Mazin
    Carraro, Raffaele
    Finer, Nick
    Kunesova, Marie
    Lindegaard, Marie L.
    Niskanen, Leo
    Rasmussen, Mats Frederik
    Rissanen, Aila
    Rossner, Stephan
    Savolainen, Markku J.
    Van Gaal, Luc
    OBESITY, 2010, 18 : S153 - S153
  • [26] Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes
    Feinglos, MN
    Saad, MF
    Pi-Sunyer, FX
    An, B
    Santiago, O
    DIABETIC MEDICINE, 2005, 22 (08) : 1016 - 1023
  • [27] Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomised controlled trial
    Andersen, E.
    Juhl, C. R.
    Kjoller, E. T.
    Lundgren, J. R.
    Janus, C.
    Saupstad, M.
    Ingerslev, L. R.
    Jensen, S. B. K.
    Holst, J. J.
    Stallknecht, B. M.
    Madsbad, S.
    Torekov, S. S.
    Barres, R.
    HUMAN REPRODUCTION, 2022, 37
  • [28] Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet
    Jensen, Simon Birk Kjaer
    Lundgren, Julie Rehne
    Janus, Charlotte
    Juhl, Christian Rimer
    Olsen, Lisa Moller
    Rosenkilde, Mads
    Holst, Jens Juul
    Stallknecht, Bente Merete
    Madsbad, Sten
    Torekov, Signe Sorensen
    BMJ OPEN, 2019, 9 (11):
  • [29] A meta-analysis of six clinical trials demonstrates that the once-daily human GLP-1 analogue liraglutide reduces systolic blood pressure
    Fonseca, V.
    Falahati, A.
    Zychma, M.
    Madsbad, S.
    Plutzky, J.
    DIABETOLOGIA, 2009, 52 : S299 - S299
  • [30] Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials
    Wang, B.
    Zhong, J.
    Lin, H.
    Zhao, Z.
    Yan, Z.
    He, H.
    Ni, Y.
    Liu, D.
    Zhu, Z.
    DIABETES OBESITY & METABOLISM, 2013, 15 (08): : 737 - 749
12345